Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $1.6 million.

  • RxSight's Change in Accured Expenses fell 5819.01% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$89000.0, marking a year-over-year decrease of 10194.32%. This contributed to the annual value of $5.9 million for FY2024, which is 15363.01% up from last year.
  • RxSight's Change in Accured Expenses amounted to $1.6 million in Q3 2025, which was down 5819.01% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Change in Accured Expenses ranged from a high of $3.7 million in Q3 2024 and a low of -$6.2 million during Q1 2025
  • For the 5-year period, RxSight's Change in Accured Expenses averaged around $689789.5, with its median value being $1.5 million (2023).
  • As far as peak fluctuations go, RxSight's Change in Accured Expenses skyrocketed by 42104.21% in 2021, and later plummeted by 19116.47% in 2022.
  • RxSight's Change in Accured Expenses (Quarter) stood at $1.6 million in 2021, then soared by 51.44% to $2.4 million in 2022, then fell by 9.52% to $2.2 million in 2023, then soared by 58.72% to $3.5 million in 2024, then tumbled by 55.31% to $1.6 million in 2025.
  • Its Change in Accured Expenses stands at $1.6 million for Q3 2025, versus $1.0 million for Q2 2025 and -$6.2 million for Q1 2025.